Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001140361-15-031315
Filing Date
2015-08-12
Accepted
2015-08-12 15:27:05
Documents
1
Effectiveness Date
2015-08-12
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 6940
  Complete submission text file 0001140361-15-031315.txt   7997
Mailing Address 12636 HIGH BLUFF DRIVE, SUITE 400 SAN DIEGO CA 92130
Business Address 12636 HIGH BLUFF DRIVE, SUITE 400 SAN DIEGO CA 92130 (619) 992-6488
Genoa Pharmaceuticals, Inc. (Filer) CIK: 0001540171 (see all company filings)

EIN.: 452463191 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-187115 | Film No.: 151046810